Supporting Trials
We work in partnership with a range of organisations on large scale multi-centre clinical trials. Discover some of the projects we're currently collaborating on.
Supporting trials
Trial name | Description | Collaborator | Status |
AVAST-M | A trial looking at bevacizumab after surgery for melanoma skin cancer |
Cancer Research UK | Results |
COPERS | Can we identify how programmes aimed at promoting self management in musculoskeletal pain work and who benefits? A systematic review of sub-group analysis within RCTs. | Barts and the London School of Medicine and Dentistry | Writing up results |
COUGAR-2 | A trial looking at docetaxel chemotherapy for advanced cancer of the stomach, the oesophagus or the junction of the stomach and oesophagus | Cancer Research UK | Results |
LIHNCS | A trial looking at using a dye during surgery for mouth and throat cancer. | Cancer Research UK |
Closed |
LIPOS | Liraglutide in PCOS (LIPOS) Study: Evaluation of the Efficacy of Liraglutide on Menstrual Cyclicity in Women with PCOS - a prospective randomised double-blind placebo-controlled study | Reproductive health | Closed |
Neo-escape | A trial looking at chemotherapy before and after surgery for advanced peritoneal cancer |
Cancer Research UK | Results |
Neo-tAnGo | A trial looking at chemotherapy before surgery for breast cancer | Cancer Research UK | Results |
OSCAR | The trial is comparing conventional positive pressure ventilationwith high frequency oscillatory ventilation (HFOV) for adults with acute respiratory distress syndrome. | University of Oxford | Completed |
PG-SNPS | A study looking at why people respond differently to the same chemotherapy | Cancer Research UK | Closed |
TANDEM |
Investigating whether a cognitive behavioural approach (CBA) intervention, delivered prior to PR can help to improve mild to moderate anxiety and/or depression in those with moderate to very severe COPD and consequently encourage PR uptake/completion. |
Queen Mary University of London | Follow-up |
VICTOR | The trial’s aim was to answer the question of whether VIOXX®, a potent orally active COX-2 inhibitor licensed for use in osteoarthritis, has a role as maintenance therapy in colorectal cancer patients following potentially curative therapy. | University of Oxford | Completed |
WHITE | Exploring a research framework that can provide meaningful data regarding the clinical and cost effectiveness of treatments of fracture of the proximal femur | University of Oxford | Recruiting |